Review Article
A Narrative Review on Therapeutic Potentials of Watercress in Human Disorders
Table 2
The clinical trials and cell line studies for watercress.
| Gill CI et al. | A single-blind, randomized, crossover study | 85 g raw watercress daily for 8 week | WC supplementation reduces lymphocyte DNA damage and alters blood antioxidant status [21] |
| Fogarty et al. | Randomized controlled investigation | Acute (consumption 2 h before exercise) and chronic (8 weeks consumption) | Acute and chronic WC supplementation attenuates exercise-induced peripheral mononuclear cell DNA damage and lipid peroxidation [44] |
| Hofmann et al. | — | 85 g WC per day for 8 weeks | WC modulated the enzymes SOD and GPX in blood cells in vitro and in vivo [55] |
| Boyd et al. | Human colon cancer cells (HT29) | — | WC extract protective against the three stages of the carcinogenesis process [56] |
| Lhoste et al. | Human HepG2 cells | — | WC acted as a bifunctional inducer by enhancing both phase I and phase II enzymes [58] |
| Hecht et al. | — | 2 ounces (56.8 g) of watercress at each meal for 3 days | Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers [78] |
| Rose et al. | Human MDA-MB-231 breast cancer cells | — | WC suppressed matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells [79] |
|
|